To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 1,406.00 <%= Resources.Global.txtUp %>
Updated 16:20:00
Change % 0.86% Stock price increasing
Change 12.00 Stock price increasing
Volume 215,974
High DKK 1,409.00
Low DKK 1,387.00
Open DKK 1,404.00
ISIN DK0010272202
Prev close DKK 1,394.00
# of shares 60.74M
Market cap 85,394M DKK
Intraday

Market closed
Genmab A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,406.00 -4.7% Stock price decreasing 2.6% Stock price increasing 23.2% Stock price increasing 23.0% Stock price increasing 64.3% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 49.74 63.1% Stock price increasing 63.1% Stock price increasing 63.1% Stock price increasing 63.1% Stock price increasing 63.1% Stock price increasing 63.1% Stock price increasing
 
Bristol-Myers Squibb Company 55.89 -0.7% Stock price decreasing -1.0% Stock price decreasing -6.2% Stock price decreasing -1.0% Stock price decreasing -10.6% Stock price decreasing -4.4% Stock price decreasing
 
Johnson & Johnson 125.48 -2.0% Stock price decreasing 2.2% Stock price increasing 8.2% Stock price increasing 5.6% Stock price increasing 15.9% Stock price increasing 8.9% Stock price increasing
 
Pfizer Inc 34.00 -0.9% Stock price decreasing -0.8% Stock price decreasing 4.7% Stock price increasing -0.8% Stock price decreasing 13.0% Stock price increasing 4.7% Stock price increasing
 
Amgen Inc 165.74 -1.7% Stock price decreasing -5.1% Stock price decreasing 12.3% Stock price increasing -5.2% Stock price decreasing 11.1% Stock price increasing 13.4% Stock price increasing
 
Bavarian Nordic A/S 346.00 -1.1% Stock price decreasing 22.3% Stock price increasing 45.4% Stock price increasing 30.6% Stock price increasing 39.8% Stock price increasing 39.0% Stock price increasing
 
Merck Kgaa O.N. 103.85 -0.1% Stock price decreasing 0.6% Stock price increasing 5.0% Stock price increasing 6.1% Stock price increasing 40.2% Stock price increasing 4.7% Stock price increasing
 
Novartis NAM SF 0,50 68.87 -2.4% Stock price decreasing -5.3% Stock price decreasing 0.1% Stock price increasing -5.2% Stock price decreasing 5.1% Stock price increasing -0.3% Stock price decreasing
 
Roche Hldg AG GEN 235.45 -0.5% Stock price decreasing 1.5% Stock price increasing 8.9% Stock price increasing 4.7% Stock price increasing 8.8% Stock price increasing 8.9% Stock price increasing
 
Biogen Inc 274.82 -0.5% Stock price decreasing -3.6% Stock price decreasing -4.4% Stock price decreasing -12.1% Stock price decreasing 7.9% Stock price increasing -3.1% Stock price decreasing
 
Emergent Biosolutions Inc 28.82 -5.4% Stock price decreasing -3.8% Stock price decreasing -14.2% Stock price decreasing 1.6% Stock price increasing -14.6% Stock price decreasing -12.2% Stock price decreasing
 
Bayer AG NA O.N. 107.00 0.1% Stock price increasing 2.6% Stock price increasing 8.6% Stock price increasing 17.0% Stock price increasing 4.4% Stock price increasing 7.9% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,071.98 -0.8% Stock price decreasing 0.6% Stock price increasing 6.1% Stock price increasing 4.1% Stock price increasing 7.7% Stock price increasing 5.1% Stock price increasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 Cap 1,071.98 0.2% Stock price increasing
38,44,12,28,9,13,18,30,36,86
Instruments Last Change  
Eisai CO Ltd 49.74 0.7% Stock price increasing
0,0,0,0,0,0,0,0,0,0
Bristol-Myer.. 55.89 0.2% Stock price increasing
13,76,80,56,61,51,53,34,50,36
Johnson & Jo.. 125.48 -0.3% Stock price decreasing
61,85,94,76,63,46,45,25,41,21
Pfizer Inc 34.00 -0.9% Stock price decreasing
100,33,59,31,44,31,33,13,40,12
Amgen Inc 165.74 -0.2% Stock price decreasing
52,59,64,68,88,72,41,21,30,35
Bavarian Nor.. 346.00 0.4% Stock price increasing
42,28,28,28,42,71,57,42,57,71
Merck Kgaa O.. 103.85 1.7% Stock price increasing
6,52,74,95,90,89,74,62,47,54
Novartis NAM.. 68.87 -0.7% Stock price decreasing
89,81,71,84,71,35,7,10,24,32
Roche Hldg A.. 235.45 0.0% Stock price decreasing
91,57,75,64,53,46,46,83,100,55
Biogen Inc 274.82 -0.2% Stock price decreasing
47,70,74,66,54,42,22,0,28,34
Emergent Bio.. 28.82 1.6% Stock price increasing
11,92,65,84,63,57,81,62,72,84
Bayer AG NA .. 107.00 0.1% Stock price increasing
8,56,84,100,76,44,60,40,48,24

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/JPMorgan: Hæver kursmål til 1500 kr.
JPMorgan
1,500 op
23/02/17
Genmab/Goldman: Kursmålet hæves til 1370 kr.
Goldman Sachs
1,370
17/01/17
Genmab/ABG: Løfter kursmål med 400 kr. til 1500 kr.
ABG Sundal Collier
1,500 op
07/06/16
KORR: Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Danske: Løfter kursmål til 1300 kr. fra 1145 kr.
Danske Bank
1,300 op
23/05/16

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 March 2017 23:59:29
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170324.2 - EUROWEB3 - 2017-03-25 00:59:29 - 2017-03-24 23:59:29 - 1000 - Website: OKAY